Benzinga's Top Upgrades
October 23, 2014 at 08:45 AM EDT
Goldman Sachs upgraded Boston Scientific (NYSE: BSX) from Sell to Neutral. The price target for Boston Scientific has been raised from ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.